Caricamento...
Estimating Cancer Risk from Tc-99m Pyrophosphate Imaging for Transthyretin Cardiac Amyloidosis
BACKGROUND: Increasing recognition that transthyretin cardiac amyloidosis (ATTR-CA) is much more common than previously appreciated, and the emergence of novel disease-modifying therapeutic agents, have led to a paradigm shift in which ATTR-CA screening is considered in high-risk populations, such a...
Salvato in:
| Pubblicato in: | J Nucl Cardiol |
|---|---|
| Autori principali: | , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2018
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6269210/ https://ncbi.nlm.nih.gov/pubmed/29850972 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12350-018-1307-7 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|